President Donald Trump disclosed a position in Corcept Therapeutics (NASDAQ: CORT) on March 4, when the pharmaceutical company was trading at $35.69. Since then, Concept Therapeutics stock has surged roughly 228% and trades at $117.17 as of the time of writing, August 18. As a result, Trump’s March 4 position, then valued in the $15,001-50,000 range, is now worth approximately $49,000-$164,000. As the actual number of shares and exact purchase p…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.